# Low Dose Sirolimus or CsA-Based Maintenance Immunosuppression After Induction With Campath-1 in Kidney Transplantation

> **NCT00309270** · PHASE2 · COMPLETED · sponsor: **Mario Negri Institute for Pharmacological Research** · enrollment: 21 (—)

## Conditions studied

- Kidney Transplant

## Interventions

- **DRUG:** Campath-1H

## Key facts

- **NCT ID:** NCT00309270
- **Lead sponsor:** Mario Negri Institute for Pharmacological Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** —
- **Final completion:** 2010-04
- **Target enrollment:** 21 (—)
- **Last updated:** 2006-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00309270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00309270, "Low Dose Sirolimus or CsA-Based Maintenance Immunosuppression After Induction With Campath-1 in Kidney Transplantation". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00309270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*